Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sri Rejeki Isman Tbk. (SRIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Sri Rejeki Isman Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Sri Rejeki Isman Tbk. trades at Rp146 (market cap 2.99T). The key difference: Sri Rejeki Isman Tbk. is far larger — about 18× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | SRIL | |
|---|---|---|
Market Cap | 166.01B | 2.99T |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Sri Rejeki Isman Tbk.
PT Sri Rejeki Isman Tbk (the Company) was establised based on Notarial Deed No. 48 dated May 22, 1978 of Ruth Karliena, S.H., notary in Surakarta.
Read more on SRIL →
